State of Competition / Antitrust (Page 3)
October 3, 2017 In Antitrust, Private Enforcement By Dr. Valentin Mircea

Implementation of the EU Damages Directive in Central and Eastern European Countries (Chapter on Romania)

The Central and Eastern Europe (Poland, Romania, Lithuania, Estonia, Latvia, Hungary, Czech Republic, Slovakia, Croatia) still lags behind some countries in the West of the European Union - particularly the United Kingdom, Germany and The Netherlands - in terms of actions for damages produced by...

0
0
September 25, 2017 In Antitrust, Cases and Decisions, Cases and Decisions By Dr. Valentin Mircea

Competition Case Law Digest – A synthesis of EU and national leading cases

2018 Competition Case Law Digest - A synthesis of EU and national leading cases - Now Available This Digest is the most comprehensive country-by-country description and analysis by local experts of competition law regimes in EU, Member States, US and China. This 3rd edition includes 30...

0
0
June 19, 2015 In Cases and Decisions, Distribution By Dr. Valentin Mircea

Retail price fixing – when it is and when it is not (the case of Germany and Romania)

At the end of 2014 the Romanian Competition Council sanctioned Metro, Selgros, Mega Image (Delhaize) and almost two dozens of their suppliers (Danone and Pepsi, among them) for agreeing that promotions supported and organized in cooperation, under the condition of exclusivity, were deemed to constitute...

0
0
November 20, 2014 In Private Enforcement By Dr. Valentin Mircea

The Second Decentralisation of Competition Law—A Must for an Orderly Administration of Justice in the EU – in Global Competition Litigation Review – November 2014

I published an article in Global Competition Litigation Review, together with Emanuela Matei, which suggests that a second de-centra(GCLR)lisation of the EU competition law is necessary soon, in order to ensure the end of tensions between the private and the public enforcement and, at the...

0
0
November 19, 2014 In Health Care By Dr. Valentin Mircea

OECD about the competition issues in the distribution of pharma products – from February 2014

http://www.oecd.org/daf/competition/competition-distribution-pharmaceuticals.htm Key findings from the discussion include:Policy-makers and enforcers need to understand the distinctive economic features of the pharmaceuticals sector thoroughly to be able to intervene in this sector.Better enforcement of regulation and of competition law, more consumer information, and greater control over the incentives provided...

0
0